AquaLOX®
AquaLOX is a water-soluble version of PLT’s Boswellia Serrata extract 5-LOXIN®. 5-LOXIN has been clinically demonstrated to improve joint comfort and protect against cartilage degradation. In addition to being water-soluble, AquaLOX represents a major breakthrough with its pleasant taste profile, allowing – for the first time – the opportunity to feature PLT’s leading joint health solutions in taste-sensitive formulations such as chewables, gummies, stick-packs, shots and more.
Product families
Applications
- Cereals & Snacks
- Confectionery
- Other Food Applications
Product Families
- Phytochemicals & Plant Extracts
- Premixes & Blends
- Nutrient Premixes
- Phytochemicals
- Plant & Herb Products & Extracts
Other characteristics
- Brand
- AquaLOX
- Ingredient Name
- Boswellia Extract
- Labeling Claims
- GMO-free, Gluten-free, Halal, Kosher
- GMO-free
- Gluten-free
- Halal
- Kosher
- Markets
- Food & Nutrition
- Features
- Supported by 8 pre-clinical
- & clinical studies
- Water soluble
- Neutral taste
- Low dosage
- Patent-pending
- Kosher, Halal, Gluten-Free
- Non-GMO
- Ingredient
- Boswellia Extract, Boswellic Acid
- Technology
- Food Ingredients
- Pharmaceuticals & Nutraceuticals
- HIGHLIGHTS
Clinically demonstrated to improve joint comfort and reduce a key cartilage-degrading enzyme, 5-LOXIN®, a potent Boswellia serrata extract, has become one of the best known ingredients in the joint health category. AquaLOX®, a newly developed extract – documented to have bioavailability similar to 5-LOXIN – opens up new formulation opportunities never before available. Produced using a specialized process, AquaLOX is low-dosage and watersoluble with a neutral organoleptic profile making it ideal for taste-sensitive formulations.. Now, AquaLOX has been clinically demonstrated in a PK study to be as bioavailable as 5-LOXIN, giving you the opportunity to deliver palatable joint health support across a new range of delivery formats.
- Certifications and Compliance
- Halal
- Kosher
- Highlights
Consumers are looking for new ways to improve joint comfort – and new delivery forms that complement today's lifestyles. AquaLOX® delivers the actives they are looking for and allows for creativity in your formulations – low dosage gummies, chews, shots, beverages, and more.; Clinical research demonstrates that AKBA-rich 5-LOXIN improves joint comfort and mobility within 7 days. Additionally, it:; Provides significant benefits in WOMAC, VAS and LFI standardized testing methodologies for joint health; Has been shown to significantly inhibit matrix metalloproteinase (MMP-3), an enzyme that breaks down cartilage and connective tissues; Is well-tolerated, easy on the stomach and is is supported by extensive safety data; In a RDBC crossover clinical trial, healthy adults took either 40 mg AquaLOX (31.2 mg AKBA) or 100 mg 5-LOXIN (30 mg AKBA) in a random order on separate occasions; Results for AUC0-∞ (Area under the curve) show similar amounts of total AKBA were absorbed with each produc
- Food and Nutrition Applications
- Chews
- Gummies
- Snacks
